chartexchange

INFI
INFINITY PHARMS INC
stockOTC

InactiveSep 29, 2023
0.016USD-4.762%(-0.001)1,141,812
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
CEO
Adelene Perkins
HQ
Cambridge, Massachusetts, USA
Sep 13, 2006 · 1-for-4 (reverse)
INFI Profile

the mission of infinity pharmaceuticals, inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of difficult-to-treat diseases, with a strong focus in oncology and inflammation. small molecule discovery and development capabilities infinity's programs arise from the integration of a broad range of research and development capabilities, including strengths in cancer biology, medicinal chemistry, clinical and translational medicine, and drug product process development and formulation. strategic alliances building on its strengths in innovative small molecule drug discovery and development, infinity has established significant alliances with leading pharmaceutical and biotechnology companies to help realize the full potential of its product pipeline. business and scientific expertise the company has assembled a team of passionate, committed, and innovative individuals who bring together their collective expertise in all areas of business

INFI Performance
PeriodPriceDateChange